Follow
Oleksii Korzh / Корж Олексій
Oleksii Korzh / Корж Олексій
Харківський національний медичний університет
Verified email at knmu.edu.ua
Title
Cited by
Cited by
Year
Evolocumab and clinical outcomes in patients with cardiovascular disease
MS Sabatine, RP Giugliano, AC Keech, N Honarpour, SD Wiviott, ...
New England journal of medicine 376 (18), 1713-1722, 2017
63012017
Canagliflozin and renal outcomes in type 2 diabetes and nephropathy
V Perkovic, MJ Jardine, B Neal, S Bompoint, HJL Heerspink, ...
New England journal of medicine 380 (24), 2295-2306, 2019
58412019
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
K Swedberg, M Komajda, M Böhm, JS Borer, I Ford, A Dubost-Brama, ...
The Lancet 376 (9744), 875-885, 2010
34782010
Alogliptin after acute coronary syndrome in patients with type 2 diabetes
WB White, CP Cannon, SR Heller, SE Nissen, RM Bergenstal, GL Bakris, ...
New England journal of medicine 369 (14), 1327-1335, 2013
32012013
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
KL Ong, LK Stafford, SA McLaughlin, EJ Boyko, SE Vollset, AE Smith, ...
The Lancet 402 (10397), 203-234, 2023
18172023
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial
K Fox, I Ford, PG Steg, M Tendera, R Ferrari
The Lancet 372 (9641), 807-816, 2008
15002008
Tiotropium versus salmeterol for the prevention of exacerbations of COPD
C Vogelmeier, B Hederer, T Glaab, H Schmidt, MPMH Rutten-van Mölken, ...
New England Journal of Medicine 364 (12), 1093-1103, 2011
9892011
Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial
F Zannad, CP Cannon, WC Cushman, GL Bakris, V Menon, AT Perez, ...
The Lancet 385 (9982), 2067-2076, 2015
9092015
Rivaroxaban for thromboprophylaxis in acutely ill medical patients
AT Cohen, TE Spiro, HR Büller, L Haskell, D Hu, R Hull, A Mebazaa, ...
New England Journal of Medicine 368 (6), 513-523, 2013
7662013
Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors
MR Weir, GL Bakris, DA Bushinsky, MR Mayo, D Garza, Y Stasiv, J Wittes, ...
New England Journal of Medicine 372 (3), 211-221, 2015
7232015
EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study
KK Ray, B Molemans, WM Schoonen, P Giovas, S Bray, G Kiru, J Murphy, ...
European journal of preventive cardiology 28 (11), 1279-1289, 2021
7132021
Ivabradine in stable coronary artery disease without clinical heart failure
K Fox, I Ford, PG Steg, JC Tardif, M Tendera, R Ferrari
New England Journal of Medicine 371 (12), 1091-1099, 2014
6432014
Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure
JR Teerlink, R Diaz, GM Felker, JJV McMurray, M Metra, SD Solomon, ...
New England Journal of Medicine 384 (2), 105-116, 2021
6032021
Darapladib for preventing ischemic events in stable coronary heart disease
Stability Investigators
New England Journal of Medicine 370 (18), 1702-1711, 2014
5832014
Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride: a randomized, 24‐week, double‐blind, placebo‐controlled trial
K Strojek, KH Yoon, V Hruba, M Elze, AM Langkilde, S Parikh
Diabetes, Obesity and Metabolism 13 (10), 928-938, 2011
5512011
Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021
JD Steinmetz, GT Culbreth, LM Haile, Q Rafferty, J Lo, KG Fukutaki, ...
The Lancet Rheumatology 5 (9), e508-e522, 2023
5092023
Tiotropium Respimat inhaler and the risk of death in COPD
RA Wise, A Anzueto, D Cotton, R Dahl, T Devins, B Disse, D Dusser, ...
New England Journal of Medicine 369 (16), 1491-1501, 2013
4802013
Triglyceride lowering with pemafibrate to reduce cardiovascular risk
A Das Pradhan, RJ Glynn, JC Fruchart, JG MacFadyen, ES Zaharris, ...
New England Journal of Medicine 387 (21), 1923-1934, 2022
4782022
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in …
AJ Ferrari, DF Santomauro, A Aali, YH Abate, C Abbafati, H Abbastabar, ...
The Lancet 403 (10440), 2133-2161, 2024
4692024
Эндотелиальная дисфункция при патологии сердечно-сосудистой системы
ЛТ Малая, АН Корж, ЛБ Балковая
Харьков: Торсинг 432, 2000
4572000
The system can't perform the operation now. Try again later.
Articles 1–20